European Research Ranking Latest Projects www.researchranking.org 2026-06-26T00:14:47+02:00 ERR feed generator 239940 Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 226441.20<br>Start Date: 2022-09-01<br>End Date: 2025-02-28 2022-09-03T00:00:00+02:00 2022-09-03T00:00:00+02:00 41.3992 2.15397 228411 Senescence as a key factor in leukemogenesis and bone marrow homeostasis in aging Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 172932.48<br>Start Date: 2021-09-01<br>End Date: 2023-08-31 2021-09-01T00:00:00+02:00 2021-09-01T00:00:00+02:00 41.3992 2.15397 236393 PI3K/PTEN-related monogenic disease to understand cancer Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 4099075.20<br>Start Date: 2021-07-01<br>End Date: 2025-06-30 2021-07-01T00:00:00+02:00 2021-07-01T00:00:00+02:00 41.3992 2.15397 232818 Clinical translation of a novel CD1a-directed CAR for relapse/refractory cortical T-cell Acute Lymphoblastic Leukemia: feasibility, efficacy and safety Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 150000.00<br>Start Date: 2021-01-01<br>End Date: 2022-06-30 2021-01-31T00:00:00+01:00 2021-01-31T00:00:00+01:00 41.3992 2.15397 230747 Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells. Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 3120455.88<br>Start Date: 2021-01-01<br>End Date: 2024-12-31 2021-01-31T00:00:00+01:00 2021-01-31T00:00:00+01:00 41.3992 2.15397 228167 Mechanisms of Sirtuin-dependent regulation of immunity and leukemogenesis Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 172932.48<br>Start Date: 2020-12-01<br>End Date: 2022-11-30 2021-01-31T00:00:00+01:00 2021-01-31T00:00:00+01:00 41.3992 2.15397 218066 Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 150000.00<br>Start Date: 2019-01-01<br>End Date: 2020-06-30 2019-01-02T00:00:00+01:00 2019-01-02T00:00:00+01:00 41.3992 2.15397 215107 Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 158121.60<br>Start Date: 2019-01-01<br>End Date: 2020-12-31 2019-01-02T00:00:00+01:00 2019-01-02T00:00:00+01:00 41.3992 2.15397 215385 Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 158121.60<br>Start Date: 2018-04-01<br>End Date: 2020-03-31 2018-06-01T00:00:00+02:00 2018-06-01T00:00:00+02:00 41.3992 2.15397 186823 Cell of origin/Leukemia Initiating Cell in infant Pro-B MLL-AF4+ ALL Coordinator: FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS, Barcelona, ES<br>Funding: 100000.00<br>Start Date: 2014-05-01<br>End Date: 2018-04-30 2015-01-08T00:00:00+01:00 2015-01-08T00:00:00+01:00 41.3992 2.15397